285 related articles for article (PubMed ID: 26104054)
1. Evaluating Vitamin D Repletion Regimens and Effects in Veteran Patients.
Aterrado S; Ono G; Kanehira-Mar S; Meier J; Swislocki A
Ann Pharmacother; 2015 Sep; 49(9):969-77. PubMed ID: 26104054
[TBL] [Abstract][Full Text] [Related]
2. Cholecalciferol v. ergocalciferol for 25-hydroxyvitamin D (25(OH)D) repletion in chronic kidney disease: a randomised clinical trial.
Wetmore JB; Kimber C; Mahnken JD; Stubbs JR
Br J Nutr; 2016 Dec; 116(12):2074-2081. PubMed ID: 28065190
[TBL] [Abstract][Full Text] [Related]
3. Calculated free and bioavailable vitamin D metabolite concentrations in vitamin D-deficient hip fracture patients after supplementation with cholecalciferol and ergocalciferol.
Glendenning P; Chew GT; Inderjeeth CA; Taranto M; Fraser WD
Bone; 2013 Oct; 56(2):271-5. PubMed ID: 23792937
[TBL] [Abstract][Full Text] [Related]
4. Treatment of vitamin D deficiency within a large integrated health care delivery system.
Stratton-Loeffler MJ; Lo JC; Hui RL; Coates A; Minkoff JR; Budayr A
J Manag Care Pharm; 2012 Sep; 18(7):497-505. PubMed ID: 22971203
[TBL] [Abstract][Full Text] [Related]
5. Effects of a 10-day course of a high dose calciferol versus a single mega dose of ergocalciferol in correcting vitamin D deficiency.
Melhem SJ; Aiedeh KM; Hadidi KA
Ann Saudi Med; 2015; 35(1):13-8. PubMed ID: 26142932
[TBL] [Abstract][Full Text] [Related]
6. Differences in outcomes between cholecalciferol and ergocalciferol supplementation in veterans with inflammatory bowel disease.
Youssef D; Bailey B; Atia A; El-Abbassi A; Manning T; Peiris AN
Geriatr Gerontol Int; 2012 Jul; 12(3):475-80. PubMed ID: 22233182
[TBL] [Abstract][Full Text] [Related]
7. Ergocalciferol versus Cholecalciferol for Nutritional Vitamin D Replacement in CKD.
Mangoo-Karim R; Da Silva Abreu J; Yanev GP; Perez NN; Stubbs JR; Wetmore JB
Nephron; 2015; 130(2):99-104. PubMed ID: 26044704
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity in serum 25-hydroxy-vitamin D response to cholecalciferol in elderly women with secondary hyperparathyroidism and vitamin D deficiency.
Giusti A; Barone A; Pioli G; Girasole G; Razzano M; Pizzonia M; Pedrazzoni M; Palummeri E; Bianchi G
J Am Geriatr Soc; 2010 Aug; 58(8):1489-95. PubMed ID: 20646099
[TBL] [Abstract][Full Text] [Related]
9. Prescription ergocalciferol dosing for vitamin D repletion: a retrospective evaluation.
Vande Griend JP; McQueen RB; Linnebur SA; Vondracek SF
Pharmacotherapy; 2012 Feb; 32(2):135-41. PubMed ID: 22392422
[TBL] [Abstract][Full Text] [Related]
10. Pilot Study Evaluating Efficacy of 2 Regimens for Hypovitaminosis D Repletion in Pediatric Inflammatory Bowel Disease.
Simek RZ; Prince J; Syed S; Sauer CG; Martineau B; Hofmekler T; Freeman AJ; Kumar A; McElhanon BO; Schoen BT; Tenjarla G; McCracken C; Ziegler TR; Tangpricha V; Kugathasan S
J Pediatr Gastroenterol Nutr; 2016 Feb; 62(2):252-8. PubMed ID: 26196201
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D supplementation for prevention of mortality in adults.
Bjelakovic G; Gluud LL; Nikolova D; Whitfield K; Wetterslev J; Simonetti RG; Bjelakovic M; Gluud C
Cochrane Database Syst Rev; 2014 Jan; (1):CD007470. PubMed ID: 24414552
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of High vs. Conventional Ergocalciferol Dose for Increasing 25-Hydroxyvitamin D and Suppressing Parathyroid Hormone Levels in Stage III-IV CKD with Vitamin D Deficiency/Insufficiency: A Randomized Controlled Trial.
Thimachai P; Supasyndh O; Chaiprasert A; Satirapoj B
J Med Assoc Thai; 2015 Jul; 98(7):643-8. PubMed ID: 26267985
[TBL] [Abstract][Full Text] [Related]
13. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency.
Leventis P; Kiely PD
Scand J Rheumatol; 2009; 38(2):149-53. PubMed ID: 18991184
[TBL] [Abstract][Full Text] [Related]
14. Short and long-term variations in serum calciotropic hormones after a single very large dose of ergocalciferol (vitamin D2) or cholecalciferol (vitamin D3) in the elderly.
Romagnoli E; Mascia ML; Cipriani C; Fassino V; Mazzei F; D'Erasmo E; Carnevale V; Scillitani A; Minisola S
J Clin Endocrinol Metab; 2008 Aug; 93(8):3015-20. PubMed ID: 18492750
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis.
Hiremath GS; Cettomai D; Baynes M; Ratchford JN; Newsome S; Harrison D; Kerr D; Greenberg BM; Calabresi PA
Mult Scler; 2009 Jun; 15(6):735-40. PubMed ID: 19383644
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D2 versus vitamin D3 supplementation in hemodialysis patients: a comparative pilot study.
Daroux M; Shenouda M; Bacri JL; Lemaitre V; Vanhille P; Bataille P
J Nephrol; 2013; 26(1):152-7. PubMed ID: 22641581
[TBL] [Abstract][Full Text] [Related]
17. Dose-response effect of ergocalciferol therapy on serum 25-hydroxyvitamin D concentration during critical illness.
Dickerson RN; Berry SC; Ziebarth JD; Swanson JM; Maish GO; Minard G; Brown RO
Nutrition; 2015 Oct; 31(10):1219-23. PubMed ID: 26213135
[TBL] [Abstract][Full Text] [Related]
18. Treatment and prevention of vitamin D insufficiency in cystic fibrosis patients: comparative efficacy of ergocalciferol, cholecalciferol, and UV light.
Khazai NB; Judd SE; Jeng L; Wolfenden LL; Stecenko A; Ziegler TR; Tangpricha V
J Clin Endocrinol Metab; 2009 Jun; 94(6):2037-43. PubMed ID: 19336509
[TBL] [Abstract][Full Text] [Related]
19. Vitamin-D2 treatment-associated decrease in 25(OH)D3 level is a reciprocal phenomenon: a randomized controlled trial.
Hammami MM; Abuhdeeb K; Hammami S; Yusuf A
BMC Endocr Disord; 2019 Jan; 19(1):8. PubMed ID: 30658603
[TBL] [Abstract][Full Text] [Related]
20. A randomized controlled trial of vitamin D replacement strategies in pediatric CF patients.
Simoneau T; Sawicki GS; Milliren CE; Feldman HA; Gordon CM
J Cyst Fibros; 2016 Mar; 15(2):234-41. PubMed ID: 26211605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
